JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB40676

Anti-NAK/TBK1 antibody [EP611Y]

  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • What is this?

5

(2 Reviews)

|

(165 Publications)

Anti-NAK/TBK1 antibody [EP611Y] (ab40676) is a rabbit monoclonal antibody detecting NAK/TBK1 in Western Blot, IHC-P, ICC/IF. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 110 publications
- Trusted since 2006

View Alternative Names

NAK, TBK1, Serine/threonine-protein kinase TBK1, NF-kappa-B-activating kinase, T2K, TANK-binding kinase 1

6 Images
Immunocytochemistry/ Immunofluorescence - Anti-NAK/TBK1 antibody [EP611Y] (AB40676)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-NAK/TBK1 antibody [EP611Y] (AB40676)

ab40676 was shown to react with TBK1 in wild-type U2OSn cells in Immunocytochemistry with loss of signal observed in a TBK1 knockout cell line. Wild-type and Knockout cells were mixed and pelleted at a 1 : 1 ratio on coverslips. The cells were fixed with 4% paraformaldehyde (15 min) then permeabilized with 0.1% Triton X-100 (10min) and then blocked with 5%BSA+5%goat serum (30min). The cells were then incubated with ab40676 at 1/1500 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat anti-rabbit secondary antibody to (Alexa Fluor® 555) at 0.5 μg/ml. Acquisition of the green (wild-type), red (antibody staining) and far-red (knockout) channels was performed. Representative grayscale images of the red channel are shown. Wild-type and knockout cells are outlined with yellow and magenta dashed line, respectively. Schematic representation of the mosaic strategy used is shown on the bottom-right panel. Image was acquired with a Zeiss(LSM-880).

These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

Immunocytochemistry/ Immunofluorescence - Anti-NAK/TBK1 antibody [EP611Y] (AB40676)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-NAK/TBK1 antibody [EP611Y] (AB40676)

Immunocytochemistry/Immunofluorescence analysis of MCF7 (Human breast adenocarcinoma) cells labeling NAK/TBK1 with purified ab40676 at 1/100. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, Alexa Fluo®488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. Cells were counter-stained with ab195889 Anti-Alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor®594) at 1/200. DAPI (blue) was used as a nuclear counterstain. Secondary Only Control : PBS was used instead of the primary antibody as the negative control.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NAK/TBK1 antibody [EP611Y] (AB40676)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NAK/TBK1 antibody [EP611Y] (AB40676)

Immunohistochemical analysis of paraffin-embedded human hepatocellular carcinoma tissue sections labeling NAK/TBK1 with purified ab40676 at a dilution of 1/100 (11.5 μg/ml). ab97051 Goat Anti-Rabbit IgG H&L (HRP) at 1/500 was used as the secondary anitbody. Sections were counterstained with hematoxylin. Antigen retrieval was heat mediated using EDTA Buffer, pH 9.0. PBS was used instead of the primary antibody as the negative control and is shown in the inset.

Western blot - Anti-NAK/TBK1 antibody [EP611Y] (AB40676)
  • WB

Collaborator

Western blot - Anti-NAK/TBK1 antibody [EP611Y] (AB40676)

ab40676 was shown to react with TBK1 in wild-type U2OSn cells in Western blot with loss of signal observed in a TBK1 knockout cell line. Wild-type U2OSn and TBK1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab40676 overnight at 4 °C at a 1/10000 dilution. Blots were incubated with goat anti-rabbit HRP secondary antibodies at 1/5000 before imaging. These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Western blot - Anti-NAK/TBK1 antibody [EP611Y] (ab40676)

Predicted band size: 84 kDa

false

Western blot - Anti-NAK/TBK1 antibody [EP611Y] (AB40676)
  • WB

Lab

Western blot - Anti-NAK/TBK1 antibody [EP611Y] (AB40676)

Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : NAK knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : HepG2 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab40676 observed at 90 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab40676 was shown to specifically react with NAK when NAK knockout samples were used. Wild-type and NAK knockout samples were subjected to SDS-PAGE. ab40676 and ab8245 (loading control to GAPDH) were diluted at 1/1000 and 1/10,000 respectively and incubated overnight at 4°C. Blots were developed with goat anti-rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10,000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-NAK/TBK1 antibody [EP611Y] (ab40676)

Predicted band size: 84 kDa

false

Western blot - Anti-NAK/TBK1 antibody [EP611Y] (AB40676)
  • WB

Unknown

Western blot - Anti-NAK/TBK1 antibody [EP611Y] (AB40676)

Blocking/Diluting buffer 5% NFDM/TBST

All lanes:

Western blot - Anti-NAK/TBK1 antibody [EP611Y] (ab40676) at 1/5000 dilution

Lane 1:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

SH-SY5Y (Human neuroblastoma cell line from bone marrow) whole cell lysate at 20 µg

Lane 3:

C6 (Rat glial tumor cell line) whole cell lysate at 20 µg

Lane 4:

NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 84 kDa

Observed band size: 84 kDa

false

  • Carrier free

    Anti-NAK/TBK1 antibody [EP611Y] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP611Y

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IHC-P, ICC/IF, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody may have weak cross-reactivity with IKBKE (IKKε).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p><strong>For unpurified use at 1/1000.</strong></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p><strong>For unpurified use at 1/250 - 1/500.</strong></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100", "IHCP-species-notes": "<p><strong>For unpurified use at 1/50. </strong></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p><strong>For unpurified use at 1/1000.</strong></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000", "WB-species-notes": "<p><strong>For unpurified use at 1/1000.</strong></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-NAK/TBK1 antibody [EP611Y] (ab40676) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.

What is the molecular weight of NAK/TBK1?
Anti-NAK/TBK1 [EP611Y] (ab40676) specifically detects a band for NAK/TBK1 (UniProt: Q9UHD2) at a molecular weight of 84kDa.

Trusted by the scientific community
Anti-NAK/TBK1 [EP611Y] (ab40676) was first used in a scientific publication in 2006 and has been cited over 110 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-NAK/TBK1 antibody [EP611Y] (ab40676) has been confirmed by Western blot testing in TBK1 Knockout HAP1 cells.

Other related products
We have a range of other formats of antibody clone [EP611Y] also available for your convenience: ab40676, Carrier free - ab186470

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The NAK/TBK1 also known as TANK-binding kinase 1 is a fundamental protein kinase in various cellular processes. It weighs approximately 84 kDa and is expressed in many tissues including lymphoid organs and the brain. NAK acts as a serine/threonine-protein kinase which transfers a phosphate group to specific substrates modulating their function and activity. Phosphorylation by TBK1 initiates several signaling events making it an important regulator in immune responses and inflammatory signaling pathways.
Biological function summary

This kinase plays a significant role in antiviral defense and autophagy. NAK/TBK1 is also involved in innate immune signaling and cell survival. TBK1 forms part of a larger signaling complex interacting with adaptors like TRAF3 and TANK which are important for its proper localization and function. Phospho-NAK its phosphorylated form can activate other molecules driving various downstream immune and stress responses.

Pathways

The protein is integral to the type I interferon signaling pathway and NF-kB pathway. NAK/TBK1 interacts closely with IRF3 a transcription factor important for antiviral activity and plays a role alongside other proteins like IKKε. These interactions permit activation of genes necessary for defense mechanisms against viral pathogens and control of inflammation. In the NF-kB pathway TBK1 helps regulate cellular responses to stress and inflammatory signals.

NAK/TBK1 has associations with amyotrophic lateral sclerosis (ALS) and various cancers. Research shows connections between TBK1 mutations and ALS indicating its importance in neuronal function and health. Additionally aberrations in TBK1 activity contribute to oncogenesis as it can affect cell proliferation and survival. The protein's relation with signaling proteins such as p62/SQSTM1 highlights its diverse role in disease mechanisms making it a potential therapeutic target.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine kinase that plays an essential role in regulating inflammatory responses to foreign agents (PubMed : 10581243, PubMed : 11839743, PubMed : 12692549, PubMed : 12702806, PubMed : 14703513, PubMed : 15367631, PubMed : 15485837, PubMed : 18583960, PubMed : 21138416, PubMed : 23453971, PubMed : 23453972, PubMed : 23746807, PubMed : 25636800, PubMed : 26611359, PubMed : 32404352, PubMed : 34363755, PubMed : 32298923). Following activation of toll-like receptors by viral or bacterial components, associates with TRAF3 and TANK and phosphorylates interferon regulatory factors (IRFs) IRF3 and IRF7 as well as DDX3X (PubMed : 12692549, PubMed : 12702806, PubMed : 14703513, PubMed : 15367631, PubMed : 18583960, PubMed : 25636800). This activity allows subsequent homodimerization and nuclear translocation of the IRFs leading to transcriptional activation of pro-inflammatory and antiviral genes including IFNA and IFNB (PubMed : 12702806, PubMed : 15367631, PubMed : 25636800, PubMed : 32972995). In order to establish such an antiviral state, TBK1 form several different complexes whose composition depends on the type of cell and cellular stimuli (PubMed : 23453971, PubMed : 23453972, PubMed : 23746807). Plays a key role in IRF3 activation : acts by first phosphorylating innate adapter proteins MAVS, STING1 and TICAM1 on their pLxIS motif, leading to recruitment of IRF3, thereby licensing IRF3 for phosphorylation by TBK1 (PubMed : 25636800, PubMed : 30842653, PubMed : 37926288). Phosphorylated IRF3 dissociates from the adapter proteins, dimerizes, and then enters the nucleus to induce expression of interferons (PubMed : 25636800). Thus, several scaffolding molecules including FADD, TRADD, MAVS, AZI2, TANK or TBKBP1/SINTBAD can be recruited to the TBK1-containing-complexes (PubMed : 21931631). Under particular conditions, functions as a NF-kappa-B effector by phosphorylating NF-kappa-B inhibitor alpha/NFKBIA, IKBKB or RELA to translocate NF-Kappa-B to the nucleus (PubMed : 10783893, PubMed : 15489227). Restricts bacterial proliferation by phosphorylating the autophagy receptor OPTN/Optineurin on 'Ser-177', thus enhancing LC3 binding affinity and antibacterial autophagy (PubMed : 21617041). Phosphorylates SMCR8 component of the C9orf72-SMCR8 complex, promoting autophagosome maturation (PubMed : 27103069). Phosphorylates ATG8 proteins MAP1LC3C and GABARAPL2, thereby preventing their delipidation and premature removal from nascent autophagosomes (PubMed : 31709703). Seems to play a role in energy balance regulation by sustaining a state of chronic, low-grade inflammation in obesity, which leads to a negative impact on insulin sensitivity (By similarity). Attenuates retroviral budding by phosphorylating the endosomal sorting complex required for transport-I (ESCRT-I) subunit VPS37C (PubMed : 21270402). Phosphorylates Borna disease virus (BDV) P protein (PubMed : 16155125). Plays an essential role in the TLR3- and IFN-dependent control of herpes virus HSV-1 and HSV-2 infections in the central nervous system (PubMed : 22851595). Acts both as a positive and negative regulator of the mTORC1 complex, depending on the context : activates mTORC1 in response to growth factors by catalyzing phosphorylation of MTOR, while it limits the mTORC1 complex by promoting phosphorylation of RPTOR (PubMed : 29150432, PubMed : 31530866). Acts as a positive regulator of the mTORC2 complex by mediating phosphorylation of MTOR, leading to increased phosphorylation and activation of AKT1 (By similarity). Phosphorylates and activates AKT1 (PubMed : 21464307). Involved in the regulation of TNF-induced RIPK1-mediated cell death, probably acting via CYLD phosphorylation that in turn controls RIPK1 ubiquitination status (PubMed : 34363755). Also participates in the differentiation of T follicular regulatory cells together with the receptor ICOS (PubMed : 27135603).
See full target information TBK1

Publications (165)

Recent publications for all applications. Explore the full list and refine your search

Science advances 11:eadw4153 PubMed41061082

2025

TRAF6 integrates innate immune signals to regulate glucose homeostasis via Parkin-dependent and Parkin-independent mitophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Elena Levi-D'Ancona,Emily M Walker,Jie Zhu,Yamei Deng,Vaibhav Sidarala,Ava M Stendahl,Emma C Reck,Belle A Henry-Kanarek,Anne C Lietzke,Biaoxin Chai,Mabelle B Pasmooij,Dre L Hubers,Venkatesha Basrur,Sankar Ghosh,Linsey Stiles,Alexey I Nesvizhskii,Orian S Shirihai,Scott A Soleimanpour

eLife 14: PubMed40990917

2025

Ubiquitination-activated TAB-TAK1-IKK-NF-κB axis modulates gene expression for cell survival in the lysosomal damage response.

Applications

Unspecified application

Species

Unspecified reactive species

Akinori Endo,Chikage Takahashi,Naoko Ishibashi,Yasumasa Nishito,Koji Yamano,Keiji Tanaka,Yukiko Yoshida

Nature communications 16:7951 PubMed40858618

2025

ALS/FTD-linked TBK1 deficiency in microglia induces an aged-like microglial signature and drives social recognition deficits in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Isadora Lenoel,Matthieu Ribon,Félicie Lorenc,Aurélien Diebold,Clementine E Philibert,David Robaldo,Manel Badsi,Julianne Perronnet,Julie Lameth,Felix Berriat,Hidemi Misawa,Marie Coutelier,Raphaelle Cassel,Nadège Sarrazin,Coline Jost-Mousseau,Delphine Bohl,Stéphanie Millecamps,Michel Mallat,David Brenner,Jochen H Weishaupt,Séverine Boillée,Christian S Lobsiger

Bioactive materials 52:182-199 PubMed40538765

2025

Near-infrared light-induced photothermal and immunotherapy system for lung cancer bone metastasis treatment with simultaneous bone repair.

Applications

Unspecified application

Species

Unspecified reactive species

Guoqing Zhong,Yali Miao,Jielong Zhou,Yijie He,Wenjie Yang,Chongquan Huang,Yunhui Zhang,Jin Xiao,Bingqing Bai,Jiaqi Zhou,Renshan Li,Tiantian Wei,Yu Zhang,Shi Cheng

Biological chemistry : PubMed40366710

2025

TBK1 alleviates triptolide-induced nephrotoxic injury by up-regulating mitophagy in HK2 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Xinxin Lu,Qionghui Huang,Zhaohui He,Huanjie Zhou,Zhenwei Chen,Youjian Zhou,Tiecheng Yang,Lang-Jing Zhu

Bioactive materials 48:55-70 PubMed40303968

2025

cGAMP-targeting injectable hydrogel system promotes periodontal restoration by alleviating cGAS-STING pathway activation.

Applications

Unspecified application

Species

Unspecified reactive species

Xiang Liu,Hua Zhang,Lei Xu,Huayu Ye,Jinghuan Huang, Jing Xiang,Yunying He,Huan Zhou,Lingli Fang,Yunyan Zhang,Xuerong Xiang,Richard D Cannon,Ping Ji,Qiming Zhai

Cell structure and function 50:115-124 PubMed40254425

2025

A quantitative method to monitor STING degradation with dual-luciferase reporters.

Applications

Unspecified application

Species

Unspecified reactive species

Tsumugi Shoji,Kanako Sato,Ayumi Shinojima,Shogo Koide,Ruri Shindo,Kazune Hongo,Kojiro Mukai,Yoshihiko Kuchitsu,Tomohiko Taguchi

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 56:74-82 PubMed40109481

2025

[Molecular Mechanisms of Huangjing Zanyu Capsule in Treating Oligoasthenospermia: A Study Based on AMPK-Mediated Mitophagy].

Applications

Unspecified application

Species

Unspecified reactive species

Yuan Gao,Yiyang Guo,Mohan Wu,Yanfei Zheng

Cell discovery 11:23 PubMed40097395

2025

Trans-Golgi network tethering factors regulate TBK1 trafficking and promote the STING-IFN-I pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Jinrui Wang,Shenghui Niu,Xiao Hu,Tianxing Li,Shengduo Liu,Yingfeng Tu,Zehua Shang,Lin Zhao,Pinglong Xu,Jingwen Lin,Lu Chen,Daniel D Billadeau,Da Jia

Theranostics 15:3207-3222 PubMed40083918

2025

Enhanced therapeutic efficacy of anti-PD-1 blockade by targeting LAMP2A inhibits lysosomal degradation of STING and TBK1.

Applications

Unspecified application

Species

Unspecified reactive species

Xueying Wang,Diekuo Zhang,Jiaqing Xiao,Lei Wang,Junrong Wang,Xiaoqiao Cui,Jiaqi Tan,Yong Liu,Susheng Miao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com